181 related articles for article (PubMed ID: 17675896)
1. Cardiometabolic syndrome and chronic kidney disease: what is the link?
Sarafidis PA; Whaley-Connell A; Sowers JR; Bakris GL
J Cardiometab Syndr; 2006; 1(1):58-65. PubMed ID: 17675896
[TBL] [Abstract][Full Text] [Related]
2. Kidney disease and the metabolic syndrome.
Zhang R; Liao J; Morse S; Donelon S; Reisin E
Am J Med Sci; 2005 Dec; 330(6):319-25. PubMed ID: 16355017
[TBL] [Abstract][Full Text] [Related]
3. Introduction: organ involvement in the cardiometabolic syndrome.
Hayden MR; Stump CS; Sowers JR
J Cardiometab Syndr; 2006; 1(1):16-24. PubMed ID: 17675904
[TBL] [Abstract][Full Text] [Related]
4. Eicosanoids and renal damage in cardiometabolic syndrome.
Imig JD
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):165-74. PubMed ID: 18248310
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological strategies for kidney function preservation: are there differences by ethnicity?
Lakkis J; Weir MR
Adv Ren Replace Ther; 2004 Jan; 11(1):24-40. PubMed ID: 14730536
[TBL] [Abstract][Full Text] [Related]
6. The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome.
Sharma AM; Engeli S
J Cardiometab Syndr; 2006; 1(1):29-35. PubMed ID: 17675902
[TBL] [Abstract][Full Text] [Related]
7. Cardiometabolic syndrome and chronic kidney disease.
Lastra G; Manrique C; McFarlane SI; Sowers JR
Curr Diab Rep; 2006 Jun; 6(3):207-12. PubMed ID: 16898573
[TBL] [Abstract][Full Text] [Related]
8. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance as putative cause of chronic renal transplant dysfunction.
de Vries AP; Bakker SJ; van Son WJ; Homan van der Heide JJ; The TH; de Jong PE; Gans RO
Am J Kidney Dis; 2003 Apr; 41(4):859-67. PubMed ID: 12666073
[TBL] [Abstract][Full Text] [Related]
10. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
[TBL] [Abstract][Full Text] [Related]
11. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
Lastra G; Manrique C; Sowers JR
Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
[TBL] [Abstract][Full Text] [Related]
12. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
13. Update on the cardiometabolic syndrome.
Sowers JR
Clin Cornerstone; 2001; 4(2):17-23. PubMed ID: 11838324
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome and chronic kidney disease.
Zhang X; Lerman LO
Transl Res; 2017 May; 183():14-25. PubMed ID: 28025032
[TBL] [Abstract][Full Text] [Related]
15. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study.
Leoncini G; Viazzi F; Rosei EA; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Deferrari G; Pontremoli R
J Hypertens; 2010 Jan; 28(1):156-62. PubMed ID: 19915481
[TBL] [Abstract][Full Text] [Related]
17. The cardiometabolic syndrome as a cardiovascular risk factor.
Govindarajan G; Whaley-Connell A; Mugo M; Stump C; Sowers JR
Am J Med Sci; 2005 Dec; 330(6):311-8. PubMed ID: 16355016
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
[TBL] [Abstract][Full Text] [Related]
19. Detecting microalbuminuria and taking action in the cardiometabolic syndrome and type 2 diabetes mellitus.
Hayden MR; Kolb L; Chowdbury N; Karuparthi PR; Khanna R; Sowers JR
Mo Med; 2006; 103(5):533-8. PubMed ID: 17133759
[TBL] [Abstract][Full Text] [Related]
20. Bone metabolism and the cardiometabolic syndrome: pathophysiologic insights.
McFarlane SI
J Cardiometab Syndr; 2006; 1(1):53-7. PubMed ID: 17675897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
